SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015529
Filing Date
2018-11-09
Accepted
2018-11-09 09:01:26
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 456076
2 ex3-1.htm EX-3.1 124738
3 ex3-2.htm EX-3.2 123992
4 ex10-3.htm EX-10.3 322812
5 ex10-4.htm EX-10.4 117145
6 ex10-5.htm EX-10.5 186472
7 ex10-6.htm EX-10.6 152223
8 ex31-1.htm EX-31.1 12246
9 ex31-2.htm EX-31.2 12027
10 ex32-1.htm EX-32.1 9429
  Complete submission text file 0001493152-18-015529.txt   3000736

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE rttr-20180930.xml EX-101.INS 211460
12 XBRL SCHEMA FILE rttr-20180930.xsd EX-101.SCH 23423
13 XBRL CALCULATION FILE rttr-20180930_cal.xml EX-101.CAL 29473
14 XBRL DEFINITION FILE rttr-20180930_def.xml EX-101.DEF 90481
15 XBRL LABEL FILE rttr-20180930_lab.xml EX-101.LAB 189540
16 XBRL PRESENTATION FILE rttr-20180930_pre.xml EX-101.PRE 149516
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 181171532
SIC: 2834 Pharmaceutical Preparations